CM-110

N/A

Report date: 2026/03/19 17:15:55

Base Information

Drug NameCM-110

Drug Alias NameCM-110CM110

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-Delta-like protein 3Anti-CD3

TargetsDelta-like protein 3T cell surface glycoprotein CD3

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGuangzhou Excelmab Inc

China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Excelmab Inc

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A